Ruurd Stolp
President chez Intervet, Inc.
Profil
Dr. Ruurd Stolp is President at Intervet, Inc. He is on the Board of Directors at Malcisbo AG.
Dr. Stolp was previously employed as President by Intervet International BV and President by Intervet.
He received his undergraduate degree from the University of Utrecht.
Postes actifs de Ruurd Stolp
| Sociétés | Poste | Début |
|---|---|---|
Intervet, Inc.
 Intervet, Inc. Agricultural Commodities/MillingProcess Industries Intervet, Inc. develops, manufactures, and sales animal health products. It provides healthcare products for pets, livestock, poultry, and aquaculture. The company was founded in 1982 and is located in Millsboro, DE. | President | - |
Anciens postes connus de Ruurd Stolp
| Sociétés | Poste | Fin |
|---|---|---|
Merck Animal Health
 Merck Animal Health Pharmaceuticals: MajorHealth Technology Merck Animal Health develops, manufactures and markets a range of veterinary medicines and services. It offers products for the prevention, treatment and control of diseases in farm and companion animal species. The firm provides veterinary pharmaceuticals, vaccines and health management solutions, farmers, pet owners and governments worldwide. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | President | 01/01/2008 |
Intervet International BV
 Intervet International BV Pharmaceuticals: MajorHealth Technology Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | President | 02/01/2007 |
Malcisbo AG
 Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Directeur/Membre du Conseil | - |
Formation de Ruurd Stolp
| University of Utrecht | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Intervet International BV
Intervet International BV Pharmaceuticals: MajorHealth Technology Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | Health Technology |
Intervet, Inc.
Intervet, Inc. Agricultural Commodities/MillingProcess Industries Intervet, Inc. develops, manufactures, and sales animal health products. It provides healthcare products for pets, livestock, poultry, and aquaculture. The company was founded in 1982 and is located in Millsboro, DE. | Process Industries |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
Merck Animal Health
Merck Animal Health Pharmaceuticals: MajorHealth Technology Merck Animal Health develops, manufactures and markets a range of veterinary medicines and services. It offers products for the prevention, treatment and control of diseases in farm and companion animal species. The firm provides veterinary pharmaceuticals, vaccines and health management solutions, farmers, pet owners and governments worldwide. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands. | Health Technology |
